Nell-1 induces acrania-like cranioskeletal deformities during mouse embryonic development

Laboratory Investigation

Volumn 86, Issue 7, 2006, Pages 633-644

  Zhang, Xinli ^a   Cowan, Catherine M ^b   Jiang, Xinquan ^c   Soo, Chia ^d   Miao, Steve ^a   Carpenter, Dale ^e   Wu, Benjamin ^b   Kuroda, Shun'ichi ^f,g   Ting, Kang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f KOBE UNIVERSITY   (Japan)

^g OSAKA UNIVERSITY   (Japan)

Author keywords

Acrania; Apoptosis; Nell 1; Transgenic

Indexed keywords

ADENOVIRUS VECTOR; FAS ANTIGEN; FAS LIGAND; PROTEIN NELL1; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ACRANIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; EMBRYO; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GESTATIONAL AGE; HYPERTROPHY; MOUSE; NERVE CELL NECROSIS; NEURAL TUBE DEFECT; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SKULL DEFECT; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CRANIOSYNOSTOSES; EMBRYONIC DEVELOPMENT; FEMALE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURAL TUBE DEFECTS; NEURONS; OSTEOBLASTS; PREGNANCY;

EID: 33745163927     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700430     Document Type: Article

References (72)

1. Matsumoto A, Hatta T, Moriyama K, et al. Sequential observations of exencephaly and subsequent morphological changes by mouse exo utero development system: analysis of the mechanism of transformation from exencephaly to anencephaly. Anat Embryol (Berlin) 2002;205:7-18.
2. Laurence KM. Principles and practice of medical genetics. In: Emery AEH, Rimoin DL (eds). Churchill, Livingston, Edenburgh, 1990, pp 323-346.
3. Lemire RJ. Neural tube defects. JAMA 1988;259:558-562.
4. Lomaga MA, Henderson JT, Elia AJ, et al. Tumor necrosis factor receptor-associated factor 6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS. J Neurosci 2000;20:7384-7393.
5. Greene ND, Copp AJ. Mouse models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C Semin Med Genet 2005;135:31-41.
6. Harris MJ, Juriloff DM. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice. Teratology 1999;60:292-305.
7. Harris CP, Townsend JJ, Carey JC. Acalvaria: a unique congenital anomaly. Am J Med Genet 1993;46:694-699.
8. Ekici E, Gulmezoglu AM. Sonographic diagnosis of fetal acrania. J Clin Ultrasound 1991;19:363-366.
9. Vergani P, Ghidini A, Sirtori M, et al. Antenatal diagnosis of fetal acrania. J Ultrasound Med 1987;6:715-717.
10. Couly GF, Coltey PM, Le Douarin NM. The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 1993;117:409-429.
11. Chandran S, Lim MK, Yu VY. Fetal acalvaria with amniotic band syndrome. Arch Dis Child Fetal Neonatal Ed 2000;82:F11-F13.
12. Horstadius S. The mechanics of sea urchin development. Annee Biol 1950;26:381-398.
13. Poelmann RE. Differential mitosis and degeneration patterns in relation to the alterations in the shape of the embryonic ectoderm of early post-implantation mouse embryos. J Embryol Exp Morphol 1980;55:33-51.
14. Serbedzija GN, Bronner-Fraser M, Fraser SE. Vital dye analysis of cranial neural crest cell migration in the mouse embryo. Development 1992;116:297-307.
15. Noden DM. An analysis of migratory behavior of avian cephalic neural crest cells. Dev Biol 1975;42:106-130.
16. Tosney KW. The segregation and early migration of cranial neural crest cells in the avian embryo. Dev Biol 1982;89:13-24.
17. Chai Y, Jiang X, Ito Y, et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000;127:1671-1679.
18. Horiuchi K, Ariga T, Fujioka H, et al. Treacher Collins syndrome with craniosynostosis, choanal atresia, and esophageal regurgitation caused by a novel nonsense mutation in TCOF1. Am J Med Genet 2004;128A:173-175.
19. Dixon J, Brakebusch C, Fassler R, et al. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome. Hum Mol Genet 2000;9:1473-1480.
20. Tsuboi M, Kawakami A, Nakashima T, et al. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med 1999;134:222-231.
21. Kawakami A, Eguchi K, Matsuoka N, et al. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 1997;12:1637-1646.
22. Zhang X, Carpenter D, Bokui N, et al. Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development. J Bone Miner Res 2003;18:2126-2134.
23. Ting K, Vastardis H, Mulliken JB, et al. Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res 1999;14:80-89.
24. Watanabe TK. Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics 1996;38:273-276.
25. Kuroda S, Tanizawa K. Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein-protein interaction with protein kinase C. Biochem Biophys Res Commun 1999;265:752-757.
26. Kuroda S, Oyasu M, Kawakami M, et al. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochem Biophys Res Commun 1999;265:79-86.
27. Bornstein P, McKinney CE, LaMarca ME, et al. Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher disease. Proc Natl Acad Sci USA 1995;92:4547-4551.
28. Zhang X, Kuroda S, Carpenter D, et al. Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest 2002;110:861-870.
29. Lotz M, Hashimoto S, Kuhn K. Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 1999;7:389-391.
30. Cheema ZF, Santillano DR, Wade SB, et al. The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins. BMC Neurosci 2004;5:11.
31. Cheema ZF, Wade SB, Sata M, et al. Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J Neurosci 1999;19:1754-1770.
32. Sayah DN, Soo C, Shaw WW, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999;87:209-216.
33. Cohen SR, Holmes RE, Amis P, et al. Internal craniofacial distraction with biodegradable devices: early stabilization and protected bone regeneration. J Craniofac Surg 2000;11:354-366.
34. Inoue T, Hatayama M, Tohmonda T, et al. Mouse Zic5 deficiency results in neural tube defects and hypoplasia of cephalic neural crest derivatives. Dev Biol 2004;270:146-162.
35. Hunt JA, Hobar PC. Common craniofacial anomalies: facial clefts and encephaloceles. Plast Reconstr Surg 2003;112:606-615; quiz 616, 722.
36. Juriloff DM, Harris MJ. Mouse models for neural tube closure defects. Hum Mol Genet 2000;9:993-1000.
37. Evan GI, Brown L, Whyte M, et al. Apoptosis and the cell cycle. Curr Opin Cell Biol 1995;7:825-834.
38. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997;88:347-354.
39. Li S, Qiu F, Xu A, et al. Barhl1 regulates migration and survival of cerebellar granule cells by controlling expression of the neurotrophin-3 gene. J Neurosci 2004;24:3104-3114.
40. Liu A, Losos K, Joyner AL. FGF8 can activate Gbx2 and transform regions of the rostral mouse brain into a hindbrain fate. Development 1999;126:4827-4838.
41. Winograd J, Reilly MP, Roe R, et al. Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice. Hum Mol Genet 1997;6:369-379.
42. Ikeda A, Ikeda S, Gridley T, et al. Neural tube defects and neuroepithelial cell death in Tulp3 knockout mice. Hum Mol Genet 2001;10:1325-1334.
43. Ellies DL, Church V, Francis-West P, et al. The WNT antagonist cSFRP2 modulates programmed cell death in the developing hindbrain. Development 2000;127:5285-5295.
44. Liu YH, Tang Z, Kundu RK, et al. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 1999;205:260-274.
45. Hay E, Lemonnier J, Fromigue O, et al. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 2001;276:29028-29036.
46. Pardo J, Buferne M, Martinez-Lorenzo MJ, et al. Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression. Int Immunol 2003;15:1441-1450.
47. Ozeki N, Mogi M, Nakamura H, et al. Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells. Arch Oral Biol 2002;47:511-517.
48. Lemonnier J, Hay E, Delannoy P, et al. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol 2001;158:1833-1842.
49. French LE, Tschopp J. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover. Behring Inst Mitt 1996;97:156-160.
50. Nishimura T, Akiyama H, Yonehara S, et al. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 1995;695:137-145.
51. Voiculescu B, Nat R, Lin E, et al. Apoptosis in human embryo development: 1. Cerebral cortex. J Cell Mol Med 2000;4:284-288.
52. Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
53. Friesen C, Herr I, Krammer PH, et al. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 1996;2:574-577.
54. Boldin MP, Varfolomeev EE, Pancer Z, et al. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995;270:7795-7798.
55. Chinnaiyan AM, O'Rourke K, Tewari M, et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-512.
56. Chinnaiyan AM, Tepper CG, Seldin MF, et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996;271:4961-4965.
57. Lemire RJ. Embryology of the skull. In: Cohen MM, MacLean RE (eds). Craniosynostosis: Diagnosis, Evaluation, and Management. Oxford University Press: New York, Oxford, 2000, pp 24-34.
58. Mooney MP, Siegel MI, Smith TD, et al. Evolutionary changes in the cranial vault and base: establishing the primate form. In: Mooney MP, Siegel MI (eds). Understanding Craniofacial Anomalies, The Etiopathogenesis of Craniosynostoses and Facial Clefting. Wiley-Liss, Inc.: New York, 2002, pp 275-294.
59. Cohen MM, MacLean RE. Apert syndrome. In: Cohen MM, MacLean RE (eds). Craniosynostosis, Diagnosis, Evaluation, and Management. Oxford University Press: Oxford, 2000, pp 316-353.
60. Virchow H. Ueber den Cretinismus, namentlich in Franken, und ueber pathologische Schaedelforamen. Verh Phys Med Ges Wuerzburg 1852;2:230-271.
61. Avantaggiato A, Carinci F, Curioni C. Apert's syndrome: cephalometric evaluation and considerations on pathogenesis. J Craniofac Surg 1996;7:23-31.
62. Nichols DH. Neural crest formation in the head of the mouse embryo as observed using a new histological technique. J Embryol Exp Morphol 1981;64:105-120.
63. Zhang J, Hagopian-Donaldson S, Serbedzija G, et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 1996;381:238-241.
64. Hatakeyama S, Tomichi N, Ohara-Nemoto Y, et al. The immunohistochemical localization of Fas and Fas ligand in jaw bone and tooth germ of human fetuses. Calcif Tissue Int 2000;66:330-337.
65. Radlanski RJ, Renz H, Klarkowski MC. Prenatal development of the human mandible. 3D reconstructions, morphometry and bone remodelling pattern, sizes 12-117 mm CRL. Anat Embryol (Berlin) 2003;207:221-232.
66. Schneider RA, Helms JA. The cellular and molecular origins of beak morphology. Science 2003;299:565-568.
67. Frommer J, Margolies MR. Contribution of Meckel's cartilage to ossification of the mandible in mice. J Dent Res 1971;50:1260-1267.
68. Sperber GH. Craniofacial Development. B.C. Decker: London, 2001.
69. Richany SF, Bast TH, Anson BJ. The development of the first branchial arch in man and the fate of Meckel's cartilage. Q Bull Northwest Univ Med Sch 1956;30:331-355.
70. Chung KS, Park HH, Ting K, et al. Modulated expression of type X collagen in Meckel's cartilage with different developmental fates. Dev Biol 1995;170:387-396.
71. Bhaskar SN, Weinmann JP, Schour I. Role of Meckel's cartilage in the development and growth of the rat mandible. J Dent Res 1953;32:398-410.
72. Stegmann K, Boecker J, Richter B, et al. A screen for mutations in human homologues of mice exencephaly genes Tfap2alpha and Msx2 in patients with neural tube defects. Teratology 2001;63:167-175.